Attys For Gilead, Drug Buyers Trade Barbs As $3.6B Trial Ends
Gilead's lawyer on Wednesday slammed a $3.6 billion antitrust suit alleging an illegal "pay-for-delay" deal with Teva over two HIV drugs during closing arguments, calling the plaintiffs' theory a "house of...To view the full article, register now.
Already a subscriber? Click here to view full article